Augurex Life Sciences Corp.

About

Augurex Life Sciences Corp. is a biotechnology company based in Vancouver, British Columbia, specializing in biomarker-driven clinical diagnostics for autoimmune conditions, including rheumatoid arthritis and axial spondyloarthritis. Founded in 2007, Augurex develops blood tests that facilitate early diagnosis, treatment monitoring, and detection of joint damage, supporting personalized medicine and improving patient outcomes. The company's flagship product, JOINTstat®, is a blood test that measures the 14-3-3η protein, aiding in the diagnosis and management of rheumatoid arthritis. Additionally, Augurex offers Anti-14-3-3η Multiplex Analyte Specific Reagents, which are used in diagnostic tests, including a first-in-class test for axial spondyloarthritis. Augurex holds several patents related to arthritis and autoimmune diseases, emphasizing its commitment to innovative diagnostic solutions that enhance healthcare workflows and patient care.